The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.
The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS.
Active, not recruiting · NCT04562831 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS. | Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder | Active, not recruiting | Not applicable | 2026-10-05 | NCT04562831 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elysium Health | 7 |
| Haukeland University Hospital | 163 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Akershus University Hospital | Lørenskog | Norway | 16 |
| Haukeland University Hospital | Bergen | Norway | 52 |
| Helse Fonna HF | Haugesund | Norway | 3 |
| Helse Førde HF | Førde | Norway | 2 |
| Oslo University Hospital | Oslo | Norway | 111 |
| St.Olavs Hospital HF | Trondheim | Norway | 1 |
| Stavanger University Hospital | Stavanger | Norway | 36 |
| Universitetssykehuset Nord-Norge | Tromsø | Norway | 5 |
| Vestre Viken HF | Drammen | Norway | 4 |